Immunomodulation and COVID-19: Is There a Winning Combination?

Coronavirus disease-2019 (COVID-19) has been testing the boundaries of science on several fronts. Pharmacotherapy has seen the highs of several drugs being tried as the best option as well as the lows of no drug proven to be effective. In this edition of the Indian Journal of Critical Care Medicine,...

Descripción completa

Detalles Bibliográficos
Autor principal: Samavedam, Srinivas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Jaypee Brothers Medical Publishers 2020
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7751030/
https://www.ncbi.nlm.nih.gov/pubmed/33384504
http://dx.doi.org/10.5005/jp-journals-10071-23691
_version_ 1783625591287709696
author Samavedam, Srinivas
author_facet Samavedam, Srinivas
author_sort Samavedam, Srinivas
collection PubMed
description Coronavirus disease-2019 (COVID-19) has been testing the boundaries of science on several fronts. Pharmacotherapy has seen the highs of several drugs being tried as the best option as well as the lows of no drug proven to be effective. In this edition of the Indian Journal of Critical Care Medicine, Mahale et al. retrospectively evaluated a combination of drugs targeted at immunomodulation. HOW TO CITE THIS ARTICLE: Samavedam S. Immunomodulation and COVID-19: Is There a Winning Combination? Indian J Crit Care Med 2020;24(11):1015–1017.
format Online
Article
Text
id pubmed-7751030
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Jaypee Brothers Medical Publishers
record_format MEDLINE/PubMed
spelling pubmed-77510302020-12-30 Immunomodulation and COVID-19: Is There a Winning Combination? Samavedam, Srinivas Indian J Crit Care Med Editorial Coronavirus disease-2019 (COVID-19) has been testing the boundaries of science on several fronts. Pharmacotherapy has seen the highs of several drugs being tried as the best option as well as the lows of no drug proven to be effective. In this edition of the Indian Journal of Critical Care Medicine, Mahale et al. retrospectively evaluated a combination of drugs targeted at immunomodulation. HOW TO CITE THIS ARTICLE: Samavedam S. Immunomodulation and COVID-19: Is There a Winning Combination? Indian J Crit Care Med 2020;24(11):1015–1017. Jaypee Brothers Medical Publishers 2020-11 /pmc/articles/PMC7751030/ /pubmed/33384504 http://dx.doi.org/10.5005/jp-journals-10071-23691 Text en Copyright © 2020; Jaypee Brothers Medical Publishers (P) Ltd. © The Author(s). 2020 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted use, distribution, and non-commercial reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Editorial
Samavedam, Srinivas
Immunomodulation and COVID-19: Is There a Winning Combination?
title Immunomodulation and COVID-19: Is There a Winning Combination?
title_full Immunomodulation and COVID-19: Is There a Winning Combination?
title_fullStr Immunomodulation and COVID-19: Is There a Winning Combination?
title_full_unstemmed Immunomodulation and COVID-19: Is There a Winning Combination?
title_short Immunomodulation and COVID-19: Is There a Winning Combination?
title_sort immunomodulation and covid-19: is there a winning combination?
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7751030/
https://www.ncbi.nlm.nih.gov/pubmed/33384504
http://dx.doi.org/10.5005/jp-journals-10071-23691
work_keys_str_mv AT samavedamsrinivas immunomodulationandcovid19isthereawinningcombination

Ejemplares similares